MedTrace Logo

Diabetic Neuropathy in Spinal Cord Stimulator Patients

NCT04687215 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-02-05

No results posted yet for this study

Summary

The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.

Conditions

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Magdalena Anitescu, MD, PhD · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-27
Primary Completion
2026-08-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04687215 on ClinicalTrials.gov